Administration ofthe beta, adrenergic agonists fenoterol, salbutamol and terbutaline to volunteers significantly reduced plasma potassium concentration in a double-blind crossover study. There was no consistent effect of the three active compounds on erythrocyte sodium concentration. Storage of whole blood at 4°C increased erythrocyte sodium concentration by 33% after 2 h; this could explain the differences between this and another study of the effects of'beta, adrenergic agonists on erythrocyte sodium concentration. We conclude that the human erythrocyte is unsuitable as an indirect in vivo model to demonstrate stimulation of cellular sodium potassium transport mediated by beta, adrenergic agonists.
Selective beta, ({32) adrenergic agonists have been shown to decrease plasma potassium (K +).1 The mechanism responsible is considered to be stimulation of {32 receptors which activate membrane bound sodium Na+-K+-ATPase, resulting in a shift of K + from the extracellular to the intracellular space.' It is thought that the main site of action is skeletal muscle and that it is mediated by cyclic AMP.l
The human erythrocyte membranes contain a small number of /32 adrenergic receptors," and the possibility has been raised that the human erythrocyte may be used as an in vivo model of Na + transport activation mediated by {32 adrenergic agonists. Thus Bodemann et al? demonstrated a simultaneous drop in plasma K + and erythrocyte Na + during infusion of both fenoterol and hexoprenaline, and also during ergometric exercise. They conclude that {3-adrenoceptor stimulation in vivo activates erythrocyte Na + transport mediated by membrane bound Na +-K +-ATPase.
To examine whether human erythrocytes are an adequate in vivo model to study Na + transport activation mediated by /32 adrenergic agonists, we investigated whether the hypokalaemic effects of nebulised fenoterol, salbutamol and terbutaline were related to significant changes in erythrocyte Na + concentration. We also examined the effects Correspondence: R W L Siebers.
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of cold storage of heparinised whole blood on erythrocyte Na + concentration to attempt to explain differences found between our results and those of Bodemann et al?
Methods

STUDIES IN VOLUNTEERS
Four healthy male volunteers were studied on four occasions, one week apart, after an overnight fast to assess the relationship between plasma K + and erythrocyte Na + after {32 adrenergic agonist stimulation in vivo. On each occasion a cannula was placed in a forearm vein, and after 10 min resting supine, two samples of blood were taken and placed into heparinised Vacutainer tubes (Becton Dickinson, New Jersey, USA) for baseline plasma and erythrocyte Na + and K + concentrations. The subjects were given either 5 mg of fenoterol, 5 mg of salbutamol, 5 mg of terbutaline or an equal volume of saline administered by a Pari-inhalierboy nebuliser to dryness. The subjects remained supine during the study and heparinised blood samples were taken at 15, 30,45,60,90 and 120 min following completion of nebulisation. The study was performed using a cross-over Latin Square design, and was doubleblind. The study was approved by the Wellington Hospital Ethical Committee and all subjects gave written informed consent.
Blood samples (5 ml) collected at the above stated times were immediately centrifuged at 2275 g for 5 min. Plasma was removed and analysed within the same analytical batch for Na + and K + by flame photometry (Radiometer FMLJ, Copenhagen, Denmark). The packed erythrocytes, from which the buffy coat was removed, were transferred into a buffered MgCh solution which is known to preserve erythrocyte Na + concentrations." The solution consists of 115 mM MgCI 2 , 10 mM glucose, 10 mM MOPS, pH adjusted to 7-40 with TRIS. After processing the final (90 min) blood sample, the erythrocyte samples were triple washed with 115 mM MgCh. The packed cell column was respun for 15 min at 2275 g and the remaining supernatant and top 5 mm of cells were removed by aspiration. Fifty microlitres of the washed packed erythrocytes were pipetted with a positive displacement pipette (SMI Digitron, California, USA) into 1·0 ml and 10·0 ml of 3·0 mM LiCI respectively for Na + and K + determination by flame photometry within the same analytical batch, as previously described." Within-batch coefficients of variation were 1·32% and 0-42% respectively for erythrocyte Na + and K + concentration.
EFFECT OF COLD STORAGE OF WHOLE BLOOD
ON ERYTHROCYTE NA + CONCENTRATION Blood was collected from six healthy subjects (three male, three female, not participating in the previous study) and aliquoted into five heparinised Vacutainer tubes. One aliquot from each subject was centrifuged immediately, plasma removed and packed erythrocytes transferred into a buffered isosmolar MgCI 2 solution as described above. The other four aliquots were kept at 4°C for 15, 30, 60 and 120min respectively prior to treatment as the first specimen. The erythrocyte samples were then washed and Na + concentrations determined as described above.
STATISTICAL ANALYSIS
The results obtained are expressed as mean-±SEM. Statistical analysis of the effects of the P2 adrenergic agonists and placebo on plasma K + and erythrocyte Na + was by analysis of variance. The level of statistical significance used was P<0·05.
Results
The P2 adrenergic agonists all caused statistically significant (P<O'OOOI) reductions in plasma K+ concentration compared to placebo (Table I) . Maximum decreases in plasma K + were at 60 min for fenoterol and terbutaline, and at 45 min for salbutamol, No significant changes in plasma Na + concentration were found (data not shown). There was no consistent effect of the individual active compounds on erythrocyte Na + concentration ( Table 2 ). The maximal fall caused by salbutarnol was equalled by placebo, neither being statistically significant. None of the compounds affected erythrocyte K + concentration and the resultant Na + /K + ratios showed changes similar to those seen with erythrocyte Na +.
Cold storage (4°C) ofheparinised whole blood samples increased erythrocyte Na + concentration 
The results are mean±SEM, n=4. Saline  6·83± 1·19  6·88± 1·28  6·80± 1·13  6·55±1·08  6·63± 1·15  6·33± 1·03  Fenoterol  6·73± 1·15  6·75± 1·16  6·75± 1·08  6·70±1·12  6·53±1·15  6·62±1·11  Salbutamol  6·95±1·35  6'53± 1·03  6·48± 1·01  6·80±1·22  6·75±1·26  6·75±1·28  Terbutaline  6·65±0·83  6·73±0·86  6·70±0·91  6·85±0·97  6·78±0·89  6·80±0·82 The results are mean±SEM, n=4.
progressively over time, without a change in erythrocyte K + concentration. Erythrocyte Na + concentrations at 0, 15,30,60 and 120 min were 5·03 (0,38); 5·22 (0,35); 5·65 (0,38); 6·15 (0,36); and 6·70 (0'38) mmol/L respectively [mean (SEM), n = 6]. At the end of the 2 h cold storage period there was an increase in mean erythrocyte Na + concentration of 33·2%. The mean plasma K + concentration at 2 h was 5·8% higher as previously reported."
Discussion
In this double-blind placebo control1ed crossover study we have shown that administration of the nebulised {12 adrenergic agonists fenoterol, salbutamol and terbutaline did not significantly alter erythrocyte Na + concentrations despite decreasing plasma K + concentrations. The minor decrease in erythrocyte Na + caused by fenoterol and salbutamol, and the minor increase caused by terbutaline, was equal1ed by nebulised saline which in itself did not cause a decrease in plasma K+.
The reason for the disparity between our results and those of Bodemann et al. 5 could be one of methodology. Firstly, we used nebulised as opposed to infused {12 adrenergic agonists. Secondly, in their study the heparinised blood samples were stored on ice for up to 2 h before analysis of erythrocyte Na +. Our study has demonstrated that erythrocyte Na + concentration increased on average by 33·2% after 2 h of cold storage, in agreement with a previous study." This could account for Bodemann et al.'s finding of a statistical1y significant decline in erythrocyte Na + of 12·4% due to exposure of the erythrocyte to 4°C; and thus for their conclusion that {12 adrenergic agonist induced hypokalaemia is associated with a significant decrease in erythrocyte Na+ 5 Our study has also demonstrated the need for a placebo component in studies before possible changes can be ascribed to drug effects. Wood et al. 1O found evidence for in vivo stimulation of Na+-K+-ATPase by oral salbutamol, shown by an increased rate of clearance of plasma Rb t after a concomitant oral dose of RbCI. They, however, did not find a similar stimulation of erythrocyte Na +-K +-ATPase as judged by nonsignificant changes in erythrocyte Rb " concentrations. Their conclusion was that there was no evidence of {12 receptors being present on human erythrocytes.
Our conclusions are similar to those ofWood et al. The human erythrocyte is an inadequate indirect in vivo model to assess the {12 adrenergic agonist stimulation ofcel1ular Na +, K + transport mechanisms that is thought to occur in human skeletal muscle.
